News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More

American College of Neuropsychopharmacology (ACNP) 62nd Annual Meeting

November 8, 2023
Read More
PRESS RELEASES

PsychoGenics and Collaborations Pharmaceuticals Awarded a $1M grant to Use AI Platforms to Design New Drugs for Mental Health Disorders

September 5, 2023
Read More
POSTER

The SmartCube Platform: Use of Phenotypic Screening in Mice with Machine Learning to Identify Novel Antipsychotic Compounds

August 24, 2023
Read More
POSTER

Elucidating Pain-Related Activity in the Eeg From the Rat Spinal Nerve Ligation Model (SNL) Of Neuropathic Pain

August 24, 2023
Read More
POSTER

Evaluation of Behavioral Pain Phenotype in the Rat Monoiodoacetateand Medial Meniscal Tear Models of Osteoarthritis Pain

August 24, 2023
Read More
POSTER

Evaluation of Behavioral Pain Phenotype and Optimization of the Rat Paclitaxel and Oxaliplatin Models of Chemotherapy-Induced Peripheral Neuropathy

August 24, 2023
Read More
POSTER

In Vivo PK, Side Effect Profile, and Efficacy of Multiple Classes of Analgesics in Rats

August 24, 2023
Read More
POSTER

Evaluation of the Abuse Liability of Oxycodone in Male and Female Rats Using Two Approaches: Intravenous Self-Administration and Conditioned Place Preference

August 24, 2023
Read More
POSTER

Characterization of a Model of Parkinson’s Disease Using Synthetic α-Synuclein Inoculation to Evaluate Motor Function, Synucleinopathy, and Dopaminergic Neurotransmission.

August 24, 2023
Read More